(108 days)
K#041411,K#021305
K#041411, K#021305
No
The document describes standard oscillometric blood pressure measurement and irregular heartbeat detection, with data transfer to a PC for analysis. There is no mention of AI or ML algorithms being used for measurement, analysis, or irregular heartbeat detection.
No
The device is intended to measure blood pressure and pulse rate, and detect irregular heartbeats, which are diagnostic functions, not therapeutic. It does not actively treat or alleviate a condition.
No
Explanation: A diagnostic device is one that identifies a disease or condition. This device measures blood pressure and pulse rate and detects irregular heartbeats, but it does not diagnose a specific medical condition or disease. It provides physiological measurements and a warning for irregular heartbeat, which can be indicators of potential issues, but it does not provide a definitive diagnosis.
No
The device description clearly states it is an "Upper Arm Automatic Digital Blood Pressure Monitor" that uses an inflatable cuff and an electronic capacitive pressure sensor, indicating it is a hardware device with integrated software. While it includes accompanying software for data transfer, the core medical device is hardware.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device function: The description clearly states that this device measures blood pressure and pulse rate using a non-invasive technique involving an inflatable cuff on the upper arm. This is a physical measurement taken directly from the body, not a test performed on a sample outside the body.
- No mention of samples: The text does not mention the collection or analysis of any biological samples.
Therefore, the Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3MC1-PC, is a non-invasive medical device for measuring physiological parameters, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3MC1-PC is a device intended to measure the systolic and diastolic blood pressure and pulse rate of an adult individual by using a non-invasive technique in which an inflatable cuff is wrapped around the upper arm.
The device detects the appearance of irregular heartbeat during measurement, and gives a warning signal with the reading once the irregular heartbeat is detected.
The device can be used in connection with your personal computer (PC) running the Microlife Blood Pressure Analyzer (BPA) software. The memory data can be transferred to the PC by connecting the monitor via cable with the PC.
Product codes
DXN
Device Description
Microlife Upper Arm Automatic Blood Pressure Monitor, Model BP3MC1- PC is designed to measure the systolic and diastolic blood pressure and pulse rate of an individual by using a non-invasive MAM (Microlife Average Mode) technique in which an inflatable cuff is wrapped around the Upper arm. Our method to define systolic and diastolic pressure is similar to the auscultatory method but uses an electronic capacitive pressure sensor rather than a stethoscope and mercury manometer. The sensor converts tiny alterations in cuff pressure to electrical signals, by analyzing those signals to define the systolic and diastolic blood pressure and calculating pulse rate, which is a well - known technique in the market called the "oscillometric method".
The device detects the appearance of irregular heartbeat during measurement, and the symbol " " " "is displayed after the measurement. In addition, the device can be used in connection with your personal computer (PC) running the Microlife Blood Pressure Analyzer (BPA) software. The memory data can be transferred to the PC by connecting the monitor via cable with the PC.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Upper arm
Indicated Patient Age Range
adult individual
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing information demonstrating safety and effectiveness of the Microlife Automatic Blood Pressure Monitor, Model BP3MC1- PC in the intended environment of use is supported by testing that was conducted in accordance with the FDA November 1993 Draft "Reviewer Guidance for Premarket Notification Submissions", DCRND, which outlines Electrical, Mechanical and Environmental Performance Requirements. Moreover The following testing was conducted:
- a. Reliability Test Storage test
- b. Reliability Test Operating test
- Reliability Test Vibration test C.
- d. Reliability Test Drop test
- e. Reliability Test Life test
- f. EMC Test
- g. PC-Link Software BPA Test Report
None of the testing demonstrated any design characteristics that violated the requirements of the Reviewer Guidance or resulted in any safety hazards. It was our conclusion that the Microlife Upper Arm Automatic Blood Pressure Monitor, Model BP3MC1- PC tested met all relevant requirements of the aforementioned tests.
Clinical Tests Performed: ANSI/AAMI SP10-2002 "National Standard for Manual. Electronic or Automated Sphygmanometers" testing was performed. All relevant sections were addressed and testing conducted. The BP3MC1-PC met all relevant requirements of this standard, as applicable to our modified device. Repeat testing was not performed for the modified device, as clinical testing results were not affected by the changes to the modified device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
K#041411, K#021305
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1130 Noninvasive blood pressure measurement system.
(a)
Identification. A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the text "Exhibit #1" in bold font on the bottom left. To the right of the text is the fraction "1/4" written in a handwritten style. The text and fraction are the only elements in the image. The background is white.
510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 5I0(k) number is: K061471
1. Submitter's Identification:
Microlife Intellectual Property GmbH, Switzerland
Max Schmidheiny-Strasse 201 9435 Heerbrugg / Switzerland
Date Summary Prepared: May 25, 2006
Contact: Mr. Gerhard Frick
2. Name of the Device:
Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3MC1- PC.
3. Information for the 510(k) Cleared Device (Predicate Device):
- a. Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3BT0-AP, K#041411.
- b. Microlife Wrist Watch Automatic Blood Pressure Monitor, Model BP3BU1-5, K#021305.
Device Description: র্ব
Microlife Upper Arm Automatic Blood Pressure Monitor, Model BP3MC1- PC is designed to measure the systolic and diastolic blood pressure and pulse rate of an individual by using a non-invasive MAM (Microlife Average Mode) technique in which an inflatable cuff is wrapped around the Upper arm. Our method to define systolic and diastolic pressure is similar to the auscultatory method but uses an electronic capacitive pressure sensor rather than a stethoscope and mercury manometer. The sensor converts tiny alterations in cuff pressure to electrical signals, by analyzing those signals to define the systolic and diastolic blood pressure and calculating pulse rate, which is a well - known technique in the market called the "oscillometric method".
1
The device detects the appearance of irregular heartbeat during measurement, and the symbol " " " "is displayed after the measurement. In addition, the device can be used in connection with your personal computer (PC) running the Microlife Blood Pressure Analyzer (BPA) software. The memory data can be transferred to the PC by connecting the monitor via cable with the PC.
ട്. Intended Use:
The Microlife Upper Arm Blood Pressure Monitor, Model BP3MC1-PC is a device intended to measure the systolic and diastolic blood pressure and pulse rate of an adult individual by using a non-invasive technique in which an inflatable cuff is wrapped around the upper arm.
The device detects the appearance of irregular heartbeat during measurement, and gives a warning signal with the reading once the irregular heartbeat is detected.
The device can be used in connection with your personal computer (PC) running the Microlife Blood Pressure Analyzer (BPA) software. The memory data can be transferred to the PC by connecting the monitor via cable with the PC.
6. Comparison to the 510(k) Cleared Device (Predicate Device):
Both devices use the well-known oscillometric method within the software algorithm to determine the systolic and diastolic blood pressure and pulse rate. An upper arm cuff is inflated automatically; deflate rate is controlled but a factory set bleed valve and the deflation pressures are transferred via tubing to a sensor in both units. Moreover both devices have a pulse irregular heartbeat detection (IHD) function.
However the difference between BP3MC1- PC and the predicate devices are as follows:
1. MAM function:
BP3MC1- PC contains a switchable average mode in which the device automatically repeats 3 individual measurements cycles, each with a rest time of 15 seconds in between. After that the average of these 3 individual measurements is calculated and shown on the display. By certain key operation the user can access the individual results of the measurements.
2. PC function:
The device can be used in connection with your personal computer (PC) running the Microlife Blood Pressure Analyzer (BPA) software. The memory data can be transferred to the PC by connecting the monitor via cable with the PC.
2
7. Discussion of Non-Clinical Tests Performed for Determination of Substantial Equivalence are as follows:
Testing information demonstrating safety and effectiveness of the Microlife Automatic Blood Pressure Monitor, Model BP3MC1- PC in the intended environment of use is supported by testing that was conducted in accordance with the FDA November 1993 Draft "Reviewer Guidance for Premarket Notification
Submissions", DCRND, which outlines Electrical, Mechanical and Environmental Performance Requirements. Moreover
The following testing was conducted:
- a. Reliability Test Storage test
- b. Reliability Test Operating test
- Reliability Test Vibration test C.
- d. Reliability Test Drop test
- e. Reliability Test Life test
- f. EMC Test
- g. PC-Link Software BPA Test Report
None of the testing demonstrated any design characteristics that violated the requirements of the Reviewer Guidance or resulted in any safety hazards. It was our conclusion that the Microlife Upper Arm Automatic Blood Pressure Monitor, Model BP3MC1- PC tested met all relevant requirements of the aforementioned tests.
Discussion of Clinical Tests Performed: 8.
ANSI/AAMI SP10-2002 "National Standard for Manual. Electronic or Automated Sphygmanometers" testing was performed. All relevant sections were addressed and testing conducted. The BP3MC1-PC met all relevant requirements of this standard, as applicable to our modified device. Repeat testing was not performed for the modified device, as clinical testing results were not affected by the changes to the modified device.
9. Software information:
In keeping with current FDA policy on software level of concern, the modified device is consistent with a moderate level of concern. We provided software documentation in accordance with the FDA November 2005 document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices ". Moreover, the subject device requires the use of off-the-shelf software to operate the PC-link function, and we met all required elements as outlined in FDA's "Off the Shelf Software Guidance Document".
3
4/4
10. Conclusions:
We have demonstrated that the Microlife Wrist Watch Blood Pressure Monitor, Model BP3AX1-4U, is as safe and effective as our predicate devices, the Microlife Wrist Watch Blood Pressure Monitor, Model BP3BTO-AP, and the Microlife Wrist Watch Automatic Blood Pressure Monitor, Model BP3BU1-5, based on electrical, mechanical and environmental testing results as well as the FDA DCRND November 1993 Draft "Reviewer Guidance for Premarket Notification Submissions", and our "Risk Analysis", as supplied with this submission.
4
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings and body.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
SEP 1 1 2006
Microlife Intellectual Property GmbH c/o Ms. Susan D. Goldstein-Falk mdi Consultants, Inc. 55 Northern Blvd., Suite 200 Great Neck, New York 11021
Re: K061471
Trade Name: Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3MC1-PC Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II (two) Product Code: DXN Dated: August 16, 2006 Received: August 17, 2006
Dear Ms. Goldstein-Falk:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
5
Page 2 – Ms. Susan D. Goldstein-Falk
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
B.Brimmer for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Exhibit# B
Indications for Use
1 Page -
510(k) Number (if known): ___K061471
Device Name: Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3MC1-PC
Indications For Use:
The Microlife Upper Arm Automatic Digital Blood Pressure Monitor, Model BP3MC1-PC i he Microlic oppor Alm Ratom the systolic and diastolic blood pressure and pulse rate of is a dewoo intended to mag a non-invasive technique in which an inflatable cuff is wrapped around the upper arm.
The device detects the appearance of irregular heartbeat during measurement, and gives a warning signal with the reading once the irregular heartbeat is detected.
The device can be used in connection with your personal computer (PC) running the The device ban be assure Analyzer (BPA) software. The memory data can be transferred to the PC by connecting the monitor via cable with the PC.
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use × (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
B. Ammerman
ivision Sign-Off) Division of Cardlovascular Devices 510(k) Number k